A multimodal deep learning framework trained on paired CT and MRI data demonstrated improved diagnostic accuracy when classifying patients with Alzheimer disease, mild cognitive impairment, or normal ...
GAINESVILLE, Fla.--(BUSINESS WIRE)--Neuropacs™ Corp., an innovator in AI-enabled neurological imaging, today announced that the U.S. Food and Drug Administration has granted De Novo classification to ...
Multicenter Clinical Evidence Supports Use of neuropacs™ to Assist Clinicians in Differentiating Parkinsonian Syndromes, Strengthening Commercial Momentum Neuropacs™ Corp., an innovator in AI-enabled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results